Morbidities and comorbidities associated with optic nerve hypoplasia and septo-optic-pituitary dysplasia.

Aim: To quantify optic nerve hypoplasia (ONH) and septo-optic-pituitary dysplasia (SOD) morbidities and comorbidities.

Method: A retrospective population-based study with a case-control design was undertaken using administrative health data from Manitoba, Canada. Cases were 124 patients with ONH or SOD (70 males, 54 females; age range 6 months-36 years 8 months [mean 13 years, SD 7 years 2 months]) diagnosed from 1990 to 2019, matched to 620 unrelated population-based controls (350 males, 270 females; age range 0-36 years 8 months [mean 12 years 5 months, SD 7 years 2 months]) on birth year, sex, and area of residence.

A scoping review on the obstacles faced by beta thalassemia major patients in Pakistan- Matter of policy investment.

Beta-thalassemia major (β-TM) is a genetic disorder, prevalent especially in the Mediterranean region, Southeast Asia, and the Indian subcontinent. With improvements in management over the years, β-TM has transitioned from a fatal childhood disease to a chronic condition. However, in Pakistan, there is still a lack of a comprehensive national policy and strategic plan, which has resulted in a growing number of β-TM patients, placing a substantial burden on individuals and the national healthcare system.

Omics insights in responses of bivalves exposed to plastic pollution.

Plastic pollution, particularly microplastics and nanoplastics, poses a significant threat to marine ecosystems. Bivalves, vital filter feeders that accumulate plastic particles, underscore the necessity for advanced omics technologies to grasp their molecular reactions to plastic exposure. This review delves into the impact of microplastics and nanoplastics on bivalves utilizing advanced omics technologies.

The introduction of the SARS-CoV-2 BA.4 lineage into Pakistan.

Pakistan has experienced a total of six COVID-19 waves throughout the pandemic, each driven by distinct SARS-CoV-2 lineages. This study explores the introduction of Omicron lineage BA.4 into Pakistan, which contributed to the sixth wave between June and September 2022.